BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19343533)

  • 1. Fabry disease in a patient with Turner syndrome.
    Brouns R; Eyskens F; De Boeck K; Ceuterick-de Groote C; Van den Broeck M; Van Broeckhoven C; De Deyn PP
    J Inherit Metab Dis; 2009 Dec; 32 Suppl 1():S45-8. PubMed ID: 19343533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Japanese patients with Fabry disease predominantly showing cardiac and neurological manifestation with novel missense mutation: R220P.
    Fukutomi M; Tanaka N; Uchinoumi H; Kanemoto M; Nakao F; Yamada J; Kamei T; Takenaka T; Fujii T
    J Cardiol; 2013 Jul; 62(1):63-9. PubMed ID: 23608164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fabry disease: identification of novel alpha-galactosidase A mutations and molecular carrier detection by use of fluorescent chemical cleavage of mismatches.
    Germain DP; Poenaru L
    Biochem Biophys Res Commun; 1999 Apr; 257(3):708-13. PubMed ID: 10208848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two novel alpha-galactosidase A mutations causing Fabry disease: A missense mutation M11V in a heterozygote woman and a nonsense mutation R190X in a hemizygote man.
    Celtikci B; Topçu M; Ozkara HA
    Clin Biochem; 2011 Jul; 44(10-11):809-12. PubMed ID: 21569769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of alpha-galactosidase a mutations causing Fabry disease by denaturing high performance liquid chromatography.
    Shabbeer J; Robinson M; Desnick RJ
    Hum Mutat; 2005 Mar; 25(3):299-305. PubMed ID: 15712228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The severe clinical phenotype for a heterozygous Fabry female patient correlates to the methylation of non-mutated allele associated with chromosome 10q26 deletion syndrome.
    Hossain MA; Yanagisawa H; Miyajima T; Wu C; Takamura A; Akiyama K; Itagaki R; Eto K; Iwamoto T; Yokoi T; Kurosawa K; Numabe H; Eto Y
    Mol Genet Metab; 2017 Mar; 120(3):173-179. PubMed ID: 28087245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo mutation in a male patient with Fabry disease: a case report.
    Iemolo F; Pizzo F; Albeggiani G; Zizzo C; Colomba P; Scalia S; Bartolotta C; Duro G
    BMC Res Notes; 2014 Jan; 7():11. PubMed ID: 24398019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and genetic investigation of a Japanese family with cardiac fabry disease. Identification of a novel α-galactosidase A missense mutation (G195V).
    Nakagawa N; Maruyama H; Ishihara T; Seino U; Kawabe J; Takahashi F; Kobayashi M; Yamauchi A; Sasaki Y; Sakamoto N; Ota H; Tanabe Y; Takeuchi T; Takenaka T; Kikuchi K; Hasebe N
    Int Heart J; 2011; 52(5):308-11. PubMed ID: 22008442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel loss-of-function mutation of the GLA gene in a Chinese Han family with Fabry disease.
    Zhou C; Huang J; Cui G; Zeng H; Wang DW; Zhou Q
    BMC Med Genet; 2018 Dec; 19(1):219. PubMed ID: 30587147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel A97P amino acid substitution in alpha-galactosidase A leads to a classical Fabry disease with cardiac manifestations.
    Kimura K; Sato-Matsumura KC; Nakamura H; Onodera Y; Morita K; Enami N; Shougase T; Ohsaki T; Kato M; Takahashi T; Yamaguchi Y; Shimizu H
    Br J Dermatol; 2002 Sep; 147(3):545-8. PubMed ID: 12207598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-occurrence and contribution of Fabry disease and Klippel-Trénaunay-Weber syndrome to a patient with atypical skin lesions.
    Germain DP
    Clin Genet; 2001 Jul; 60(1):63-7. PubMed ID: 11531972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel missense mutation (M72V) of alpha-galactosidase gene and its expression product in an atypical Fabry hemizygote.
    Okumiya T; Kawamura O; Itoh K; Kase R; Ishii S; Kamei S; Sakuraba H
    Hum Mutat; 1998; Suppl 1():S213-6. PubMed ID: 9452090
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel α-galactosidase A mutation in patients with severe cardiac manifestations of Fabry disease.
    Duro G; Musumeci MB; Colomba P; Zizzo C; Albeggiani G; Mastromarino V; Volpe M; Autore C
    Gene; 2014 Feb; 535(2):365-9. PubMed ID: 24140492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel GLA mutation in a Fabry family with glucose-6-phosphate dehydrogenase deficiency.
    Pisani A; Visciano B; Russo R; Mozzillo GR; Porto C; De Maggio I; Russo R; Pontarelli G; Villani GR; Cianciaruso B; Di Natale P
    J Nephrol; 2012; 25(4):582-5. PubMed ID: 22307442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypical characterization of α-galactosidase A gene mutations identified in a large Fabry disease screening program in stroke in the young.
    De Brabander I; Yperzeele L; Ceuterick-De Groote C; Brouns R; Baker R; Belachew S; Delbecq J; De Keulenaer G; Dethy S; Eyskens F; Fumal A; Hemelsoet D; Hughes D; Jeangette S; Nuytten D; Redondo P; Sadzot B; Sindic C; Sheorajpanday R; Thijs V; Van Broeckhoven C; De Deyn PP
    Clin Neurol Neurosurg; 2013 Jul; 115(7):1088-93. PubMed ID: 23219219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel GLA mutation (Y88C) in a Korean family with Fabry nephropathy: a case report.
    Chong Y; Kim M; Koh ES; Shin SJ; Kim HS; Chung S
    BMC Med Genet; 2016 Oct; 17(1):76. PubMed ID: 27776503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a Novel GLA Gene Mutation, p.Ile239Met, in Fabry Disease With a Predominant Cardiac Phenotype.
    Csányi B; Hategan L; Nagy V; Obál I; Varga ET; Borbás J; Tringer A; Eichler S; Forster T; Rolfs A; Sepp R
    Int Heart J; 2017 May; 58(3):454-458. PubMed ID: 28496025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fabry disease. Clinical and genetic aspects. Therapeutic perspectives].
    Germain DP
    Rev Med Interne; 2000 Dec; 21(12):1086-103. PubMed ID: 11191676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel G144D mutation of the GLA gene in a Chinese patient with Fabry disease.
    Li H; Zhou FS; Wang ZX; Fu HY; Lin D; Shen SK; Zhang XJ; Yang S
    J Dermatol; 2014 May; 41(5):456-7. PubMed ID: 24801925
    [No Abstract]   [Full Text] [Related]  

  • 20. Association between polymorphisms of endothelial nitric oxide synthase gene (NOS3) and left posterior wall thickness (LPWT) of the heart in Fabry disease.
    Rohard I; Schaefer E; Kampmann C; Beck M; Gal A
    J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S349-56. PubMed ID: 18941922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.